Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $20.6B |
| FY2017, ended Dec 31, 2017 | $32.8B |
| FY2018, ended Dec 31, 2018 | $35.2B |
| FY2019, ended Dec 31, 2019 | $42.4B |
| FY2020, ended Dec 31, 2020 | $57.9B |
| FY2021, ended Dec 31, 2021 | $60.0B |
| FY2022, ended Dec 31, 2022 | $75.9B |
| FY2023, ended Dec 31, 2023 | $93.3B |
| FY2024, ended Dec 31, 2024 | $140B |
| FY2025, ended Dec 31, 2025 | $133B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $127B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $23.4B |
| FY2017, ended Dec 31, 2017 | $26.8B |
| FY2018, ended Dec 31, 2018 | $32.0B |
| FY2019, ended Dec 31, 2019 | $39.0B |
| FY2020, ended Dec 31, 2020 | $42.7B |
| FY2021, ended Dec 31, 2021 | $47.7B |
| FY2022, ended Dec 31, 2022 | $49.6B |
| FY2023, ended Dec 31, 2023 | $62.1B |
| FY2024, ended Dec 31, 2024 | $75.4B |
| FY2025, ended Dec 31, 2025 | $87.7B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $91.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.03B | $2.52B |
| FY2017, ended Dec 31, 2017 | $1.59B | $3.60B |
| FY2018, ended Dec 31, 2018 | $2.62B | $6.02B |
| FY2019, ended Dec 31, 2019 | $3.97B | $5.90B |
| FY2020, ended Dec 31, 2020 | $5.70B | $6.68B |
| FY2021, ended Dec 31, 2021 | $3.35B | $7.52B |
| FY2022, ended Dec 31, 2022 | $722M | $6.56B |
| FY2023, ended Dec 31, 2023 | $3.90B | $10.4B |
| FY2024, ended Dec 31, 2024 | $8.48B | $14.8B |
| FY2025, ended Dec 31, 2025 | $11.3B | $17.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $11.7B | $16.0B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $226M |
| FY2017, ended Dec 31, 2017 | $275M |
| FY2018, ended Dec 31, 2018 | $75.0M |
| FY2019, ended Dec 31, 2019 | $227M |
| FY2020, ended Dec 31, 2020 | $76.5M |
| FY2021, ended Dec 31, 2021 | $202M |
| FY2022, ended Dec 31, 2022 | $221M |
| FY2023, ended Dec 31, 2023 | $100M |
| FY2024, ended Dec 31, 2024 | $154M |
| FY2025, ended Dec 31, 2025 | $138M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $193M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.15B |
| FY2017, ended Dec 31, 2017 | $3.31B |
| FY2018, ended Dec 31, 2018 | $4.40B |
| FY2019, ended Dec 31, 2019 | $4.41B |
| FY2020, ended Dec 31, 2020 | $5.40B |
| FY2021, ended Dec 31, 2021 | $4.90B |
| FY2022, ended Dec 31, 2022 | $6.39B |
| FY2023, ended Dec 31, 2023 | $6.89B |
| FY2024, ended Dec 31, 2024 | $6.89B |
| FY2025, ended Dec 31, 2025 | $6.90B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $8.39B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 0.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 581M |
| FY2017, ended Dec 31, 2017 | 582M |
| FY2018, ended Dec 31, 2018 | 584M |
| FY2019, ended Dec 31, 2019 | 585M |
| FY2020, ended Dec 31, 2020 | 586M |
| FY2021, ended Dec 31, 2021 | 585M |
| FY2022, ended Dec 31, 2022 | 585M |
| FY2023, ended Dec 31, 2023 | 586M |
| FY2024, ended Dec 31, 2024 | 586M |
| FY2025, ended Dec 31, 2025 | 586M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 581M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $193M | — |
| FY2017, ended Dec 31, 2017 | — | — |
| FY2018, ended Dec 31, 2018 | — | — |
| FY2019, ended Dec 31, 2019 | — | — |
| FY2020, ended Dec 31, 2020 | — | — |
| FY2021, ended Dec 31, 2021 | — | — |
| FY2022, ended Dec 31, 2022 | — | — |
| FY2023, ended Dec 31, 2023 | — | $121M |
| FY2024, ended Dec 31, 2024 | — | $122M |
| FY2025, ended Dec 31, 2025 | — | $132M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | — |
Valuation
At current price- Market Cap
- $131B
- P/E
- 11.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.4×
- Price / Book
- 3.8×
- EV / EBITDA
- 9.0×
Growth
Trailing 12 months- Revenue (TTM)
- $91.1B
- Revenue Growth YoY
- 10.5%
- Revenue CAGR 3Y
- 20.9%
- Revenue CAGR 5Y
- 15.5%
- EPS Growth YoY
- 12.3%
- Net Income Growth YoY
- 12.1%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 12.8%
- FCF Margin
- 17.5%
- Return on Equity
- 34.9%
Earnings
Trailing 12 months- Net Income
- $11.7B
- EPS (diluted)
- $19.93
- EBITDA
- $15.4B
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $193M
- Total Debt
- $8.39B
- Net Debt
- $8.19B
- Total Assets
- $125B
- Total Liabilities
- $90.6B
- Shareholders' Equity
- $34.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $16.3B
- Capital Expenditure
- $388M
- Free Cash Flow
- $16.0B
Dividends and risk
Last 12 months- Dividend Yield
- 6.2%
- Dividend / Share
- $13.90
- Beta (5Y)
- 0.24
Every ratio is calculated from the company’s reported figures.